Cargando…
The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation
Tuberous sclerosis complex (TSC) is a genetic disorder caused by inactivating mutations in TSC1 (hamartin) or TSC2 (tuberin), crucial negative regulators of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. TSC affects multiple organs including the brain. The neurologic manif...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074262/ https://www.ncbi.nlm.nih.gov/pubmed/33923449 http://dx.doi.org/10.3390/ijms22084116 |
_version_ | 1783684315437072384 |
---|---|
author | Tang, Xin Angst, Gabrielle Haas, Michael Yang, Fuchun Wang, Chenran |
author_facet | Tang, Xin Angst, Gabrielle Haas, Michael Yang, Fuchun Wang, Chenran |
author_sort | Tang, Xin |
collection | PubMed |
description | Tuberous sclerosis complex (TSC) is a genetic disorder caused by inactivating mutations in TSC1 (hamartin) or TSC2 (tuberin), crucial negative regulators of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. TSC affects multiple organs including the brain. The neurologic manifestation is characterized by cortical tubers, subependymal nodules (SEN), and subependymal giant cell astrocytoma (SEGA) in brain. SEGAs may result in hydrocephalus in TSC patients and mTORC1 inhibitors are the current recommended therapy for SEGA. Nevertheless, a major limitation in the research for SEGA is the lack of cell lines or animal models for mechanistic investigations and development of novel therapy. In this study, we generated TSC1-deficient neural cells from spontaneously immortalized mouse astrocytes in an attempt to mimic human SEGA. The TSC1-deficient cells exhibit mTORC1 hyperactivation and characteristics of transition from astrocytes to neural stem/progenitor cell phenotypes. Rapamycin efficiently decreased mTORC1 activity of these TSC1-deficient cells in vitro. In vivo, TSC1-deficient cells could form SEGA-like tumors and Rapamycin treatment decreased tumor growth. Collectively, our study generates a novel SEGA-like cell line that is invaluable for studying mTORC1-driven molecular and pathological alterations in neurologic tissue. These SEGA-like cells also provide opportunities for the development of novel therapeutic strategy for TSC patients with SEGA. |
format | Online Article Text |
id | pubmed-8074262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80742622021-04-27 The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation Tang, Xin Angst, Gabrielle Haas, Michael Yang, Fuchun Wang, Chenran Int J Mol Sci Article Tuberous sclerosis complex (TSC) is a genetic disorder caused by inactivating mutations in TSC1 (hamartin) or TSC2 (tuberin), crucial negative regulators of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. TSC affects multiple organs including the brain. The neurologic manifestation is characterized by cortical tubers, subependymal nodules (SEN), and subependymal giant cell astrocytoma (SEGA) in brain. SEGAs may result in hydrocephalus in TSC patients and mTORC1 inhibitors are the current recommended therapy for SEGA. Nevertheless, a major limitation in the research for SEGA is the lack of cell lines or animal models for mechanistic investigations and development of novel therapy. In this study, we generated TSC1-deficient neural cells from spontaneously immortalized mouse astrocytes in an attempt to mimic human SEGA. The TSC1-deficient cells exhibit mTORC1 hyperactivation and characteristics of transition from astrocytes to neural stem/progenitor cell phenotypes. Rapamycin efficiently decreased mTORC1 activity of these TSC1-deficient cells in vitro. In vivo, TSC1-deficient cells could form SEGA-like tumors and Rapamycin treatment decreased tumor growth. Collectively, our study generates a novel SEGA-like cell line that is invaluable for studying mTORC1-driven molecular and pathological alterations in neurologic tissue. These SEGA-like cells also provide opportunities for the development of novel therapeutic strategy for TSC patients with SEGA. MDPI 2021-04-16 /pmc/articles/PMC8074262/ /pubmed/33923449 http://dx.doi.org/10.3390/ijms22084116 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tang, Xin Angst, Gabrielle Haas, Michael Yang, Fuchun Wang, Chenran The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title_full | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title_fullStr | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title_full_unstemmed | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title_short | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation |
title_sort | characterization of a subependymal giant astrocytoma-like cell line from murine astrocyte with mtorc1 hyperactivation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074262/ https://www.ncbi.nlm.nih.gov/pubmed/33923449 http://dx.doi.org/10.3390/ijms22084116 |
work_keys_str_mv | AT tangxin thecharacterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT angstgabrielle thecharacterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT haasmichael thecharacterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT yangfuchun thecharacterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT wangchenran thecharacterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT tangxin characterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT angstgabrielle characterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT haasmichael characterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT yangfuchun characterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation AT wangchenran characterizationofasubependymalgiantastrocytomalikecelllinefrommurineastrocytewithmtorc1hyperactivation |